Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kurtoglu Metin
Chief Technology Officer at Cartesian Therapeutics. Filing since 14 Nov 2024.
CIK 0002000284
Company
Date
Role
Action
Shares
Amount
Of holding
RNAC
Cartesian Therapeutics, Inc.
6 Jan 2025
Chief Technology Officer
Sold at will
2,458
$41.37K
3.8%
RNAC
Cartesian Therapeutics, Inc.
3 Jan 2025
Chief Technology Officer
Sold at will
2,417
$40.42K
3.6%
RNAC
Cartesian Therapeutics, Inc.
10 Dec 2024
Chief Technology Officer
Sold at will
2,901
$70.64K
5.4%
RNAC
Cartesian Therapeutics, Inc.
9 Dec 2024
Chief Technology Officer
Sold at will
10,763
$274.49K
17.4%
RNAC
Cartesian Therapeutics, Inc.
21 Nov 2024
Chief Technology Officer
Sold at will
32,789
$546.56K
39.1%
RNAC
Cartesian Therapeutics, Inc.
20 Nov 2024
Chief Technology Officer
Sold at will
5,700
$98.57K
10.0%
RNAC
Cartesian Therapeutics, Inc.
19 Nov 2024
Chief Technology Officer
Sold at will
200
$3.90K
0.4%
RNAC
Cartesian Therapeutics, Inc.
18 Nov 2024
Chief Technology Officer
Sold at will
34,400
$632.64K
40.3%
RNAC
Cartesian Therapeutics, Inc.
15 Nov 2024
Chief Technology Officer
Sold at will
22,068
$379.50K
30.2%
RNAC
Cartesian Therapeutics, Inc.
14 Nov 2024
Chief Technology Officer
Sold at will
25,900
$425.90K
33.7%
10 decisions on file.
